Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Agios Pharmaceuticals Inc (AGIO)  
$48.50 0.31 (0.64%) as of 4:30 Thu 7/25


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 69,110,000
Market Cap: 3.35(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $19.97 - $48.83
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Agios Pharmaceuticals is a biopharmaceutical company focused on improving patients' lives in the field of cellular metabolism and adjacent areas of biology, with the goal of creating molecule medicines for genetically defined diseases (GDD). The lead product in its GDD, portfolio, PYRUKYND® (mitapivat), is an activator of both wild-type and a variety of mutant pyruvate kinase (PK) enzymes, for the potential treatment of hemolytic anemias. Co. is evaluating PYRUKYND® for the treatment of a- and B-thalassemia and sickle cell disease (SCD). Co. is also developing AG-946, a PK activator, for the potential treatment of hemolytic anemias and other indications, including SCD.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 17,182 208,924 280,958 427,358
Total Sell Value $814,620 $6,906,082 $8,691,759 $12,601,771
Total People Sold 3 9 9 9
Total Sell Transactions 3 26 36 51
End Date 2024-04-25 2024-01-23 2023-07-25 2022-07-25

   
Records found: 804
  Page 1 of 33  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Gheuens Sarah Chief Medical Officer   •       –      –    2024-07-01 4 AS $43.85 $162,464 D/D (3,705) 43,736 7%     
   Gheuens Sarah Chief Medical Officer   •       –      –    2024-07-01 4 OE $0.00 $0 D/D 8,375 47,441     -
   Smith Cynthia Director   –       •      –    2024-06-13 4 OE $0.00 $0 D/D 3,388 5,690     -
   Foster-Cheek Kaye I Director   –       •      –    2024-06-13 4 GD $0.00 $0 D/D 3,564 5,348     -
   Foster-Cheek Kaye I Director   –       •      –    2024-06-13 4 OE $0.00 $0 D/D 3,388 8,912     -
   Schenkein David P Director   –       •      –    2024-06-13 4 OE $0.00 $0 D/D 3,388 126,242     -
   Ballal Rahul D. Director   –       •      –    2024-06-13 4 OE $0.00 $0 D/D 3,388 5,690     -
   Scadden David Director   –       •      –    2024-06-13 4 OE $0.00 $0 D/D 3,388 15,483     -
   Fouse Jacqualyn A Director   –       •      –    2024-06-13 4 OE $0.00 $0 D/D 3,388 140,784     -
   Ho Maykin Director   –       •      –    2024-06-13 4 OE $0.00 $0 D/D 3,388 14,912     -
   Owen Catherine E. Director   –       •      –    2024-06-13 4 OE $0.00 $0 D/D 1,976 1,976     -
   Capello Jeffrey D Director   –       •      –    2024-06-13 4 OE $0.00 $0 D/D 1,976 1,976     -
   Goff Brian Chief Executive Officer   •       •      –    2024-06-05 4 AS $48.84 $591,697 D/D (12,115) 67,192 -5%     
   Goff Brian Chief Executive Officer   •       •      –    2024-06-05 4 OE $0.00 $0 D/D 25,527 79,307     -
   Washburn Theodore James Jr. Principal Accounting Officer   •       –      –    2024-06-03 4 S $44.39 $60,459 D/D (1,362) 1,524 -10%     
   Fouse Jacqualyn A Director   –       •      –    2024-04-10 4 AS $27.55 $214,642 D/D (7,791) 137,396 56%     
   Fouse Jacqualyn A Director   –       •      –    2024-04-08 4 OE $0.00 $0 D/D 15,934 145,187     -
   Foster-Cheek Kaye I Director   –       •      –    2024-03-07 4 S $31.62 $40,632 D/D (1,285) 5,524 -52%     
   Foster-Cheek Kaye I Director   –       •      –    2024-03-06 4 S $31.99 $141,236 D/D (4,415) 6,809 -48%     
   Foster-Cheek Kaye I Director   –       •      –    2024-03-05 4 S $32.21 $9,663 D/D (300) 11,224 -53%     
   Washburn Theodore James Jr. Principal Accounting Officer   •       –      –    2024-03-05 4 S $31.75 $60,738 D/D (1,913) 2,886 -53%     
   Washburn Theodore James Jr. Principal Accounting Officer   •       –      –    2024-03-05 4 AS $32.57 $39,540 D/D (1,214) 4,799 53%     
   Goff Brian Chief Executive Officer   •       •      –    2024-03-05 4 AS $32.57 $135,361 D/D (4,156) 53,780 53%     
   Jones Cecilia Chief Financial Officer   •       –      –    2024-03-05 4 AS $32.57 $21,887 D/D (672) 14,840 53%     
   Gheuens Sarah Chief Medical Officer   •       –      –    2024-03-05 4 AS $32.57 $86,050 D/D (2,642) 39,066 53%     
  804 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 33
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us